Buy Clearside Biomedical Stock | CLSD Stock Price & Latest News | Public.com
CLSD

Clearside Biomedical

$0.00 (0.00%)Today
    Small Market Cap
    View Clearside Biomedical (CLSD) stock trends here

    About CLSD

    Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.04
    -0.09
    -0.13
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.08

    Actual EPS
    Q1 2021

    Stats

    Market Cap$181,34M
    Volume114,25k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.53
    1 Year Low$1.10
    Open$3.57
    High$3.58
    Low$3.30

    Buy any stock with any amount of money.

    Download the App
    Download the app